Avaleht › Ülekaalulisus › Massachusetts
Ülekaalulisus kliinilised uuringud osariigis Massachusetts
24 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid osariigis Massachusetts.
Linnad osariigis Massachusetts
Ametlik uuringutekst (inglise keeles)
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Brigham and Women's Hospital Diabetes Program, Boston
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07794579Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Lucida Clinical Trials, New Bedford
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Boston Children's Hospital, Boston
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Lucida Clinical Trials, New Bedford
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Lucida Clinical Trials, New Bedford
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Brigham and Women's Hospital Diabetes Program, Boston
- MedVadis Research Corporation, Waltham
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, North Dartmouth
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Brigham and Womens Hospital, Boston
- Btc of New Bedford, New Bedford
VärbamineFaas 3
Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Care Access - Quincy, Quincy
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Skylight Health Research - Burlington, Burlington
- Care Access - Quincy, Quincy
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Knownwell, Needham
- Lucida Clinical Trials, New Bedford
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 22. sept 2026 · NCT07589608A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Boston Medical Center, Boston
- Knownwell, Needham
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351045The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
- Massachusetts General Hospital, Boston
VärbamineFaas 4
Vanused 18–65 · Kõik sood · Uuendatud 11. sept 2026 · NCT07699445A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Methuen
VärbamineFaas 3Terved vabatahtlikud oodatud
Vanused 18–79 · Kõik sood · Uuendatud 11. sept 2026 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Knownwell, Needham
- Lucida Clinical Trials, New Bedford
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Metro Boston Clinical Partners, Brighton
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Boston
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284901Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
- Exponent Boston, Boston
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 20. aug 2026 · NCT07776678Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Methuen
- ACCOMPLISH-1 Research Site, Needham
VärbamineFaas 3
Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary Care
- Tufts Medical Center, Boston
- Tufts University, Boston
Värbamine
Vanused 12–17 · Kõik sood · Uuendatud 21. juuli 2026 · NCT07717658Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
- Cambridge Health Alliance, Sommerville
Värbamine
Vanused 18–60 · Kõik sood · Uuendatud 16. juuli 2026 · NCT06988462Time Restricted Eating (TRE) in Bipolar Disorder
- Massachusetts General Hospital, Boston
Värbamine
Vanused 18–65 · Kõik sood · Uuendatud 15. juuni 2026 · NCT07211217Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
- Massachusetts General Hospital, Boston
VärbamineVaatlusuuring
Vanused 18–65 · Kõik sood · Uuendatud 24. dets 2025 · NCT05799222Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
- Brigham and Women's Hospital, Boston
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. dets 2025 · NCT06069622Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.